Use of non-steroidal anti-inflammatory drugs in pregnancy: Impact on the fetus and newborn

Current Drug Metabolism

Volumn 13, Issue 4, 2012, Pages 474-490

  Antonucci, Roberto ^a   Zaffanello, Marco ^b   Puxeddu, Elisabetta ^c   Porcella, Annalisa ^d   Cuzzolin, Laura ^b   Pilloni, Maria Dolores ^e   Fanos, Vassilios ^c  

^a Hospital Nostra Signora di Bonaria   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY OF CAGLIARI   (Italy)

^d SAN CAMILLO HOSPITAL   (Italy)

^e Family Planning Clinic   (Italy)

Author keywords

Adverse effects; Embryo; Fetus; Indomethacin; Newborn; Non steroidal anti inflammatory drugs; NSAIDs; Pregnancy; Tocolysis

Indexed keywords

ACETYLSALICYLIC ACID; AMINOGLYCOSIDE DERIVATIVE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CELECOXIB; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; HEPARIN; IBUPROFEN; INDOMETACIN; KETOPROFEN; KETOROLAC; MAGNESIUM SULFATE; MEFENAMIC ACID; NAPROXEN; NIFLUMIC ACID; NIMESULIDE; NITRATE; NITRIC OXIDE SYNTHASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PREDNISONE; PROSTAGLANDIN E2; PROSTAGLANDIN INHIBITOR; ROFECOXIB; SULINDAC; TENOXICAM; UNINDEXED DRUG; UTERUS SPASMOLYTIC AGENT;

ABDOMINAL WALL DEFECT; ACUTE KIDNEY FAILURE; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BONE MALFORMATION; BRAIN HEMORRHAGE; CELOSOMY; CHRONIC DRUG ADMINISTRATION; CLEFT LIP; CLEFT PALATE; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; CYCLOPIA; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG METABOLISM; DRUG UTILIZATION; DUCTUS ARTERIOSUS OBLITERATION; EMBRYOPATHY; ENCEPHALOMALACIA; ENTERITIS; FETUS DISEASE; FETUS MALFORMATION; FEVER; GESTATIONAL AGE; HUMAN; HYDRAMNIOS; INFLAMMATION; INTESTINE PERFORATION; KIDNEY MALFORMATION; LOW DRUG DOSE; LUNG DYSPLASIA; NECROTIZING ENTEROCOLITIS; NEONATAL HEMORRHAGE; NEPHROTOXICITY; NEUROTOXICITY; NEWBORN DISEASE; NONHUMAN; OLIGOHYDRAMNIOS; PAIN; PATENT DUCTUS ARTERIOSUS; PERSISTENT PULMONARY HYPERTENSION; PLACENTAL TRANSFER; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RISK BENEFIT ANALYSIS; SELF MEDICATION; SPONDYLOARTHROPATHY; SPONTANEOUS ABORTION; TERATOGENICITY; TOCOLYSIS; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; FEMALE; FETUS; HUMANS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; PREGNANCY; TOCOLYTIC AGENTS;

EID: 84860623709     PISSN: 13892002     EISSN: 18755453     Source Type: Journal    
DOI: 10.2174/138920012800166607     Document Type: Article

References (244)

1. østensen, M.E.; Skomsvoll, J.F. Anti-inflammatory pharmacotherapy during pregnancy. Expert Opin. Pharmacother., 2004, 5, 571- 580. (Pubitemid 38344312)
2. Rahimi, R.; Nikfar, S.; Rezaie, A.; Abdollahi, M. Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis. Reprod. Toxicol., 2008, 25(2), 271-275.
3. Vroom, F.; van den Berg, P.B.; de Jong-van den Berg, L.T. Prescribing of NSAIDs and ASA during pregnancy; do we need to be more careful? Br. J. Clin. Pharmacol., 2008, 65, 275-276. (Pubitemid 351171261)
4. Alano, M.A.; Ngougmna, E.; Ostrea, E.M. Jr.; Konduri, G.G. Analysis of nonsteroidal antiinflammatory drugs in meconium and its relation to persistent pulmonary hypertension of the newborn. Pediatrics, 2001, 107(3), 519-523. (Pubitemid 32183186)
5. Tillett, J.; Kostich, L.M.; VandeVusse, L. Use of over-the-counter medications during pregnancy. J. Perinat. Neonatal. Nurs., 2003, 17, 3-18.
6. Ofori, B.; Oraichi, D.; Blais, L.; Rey, E.; Bérard, A. Risk of congenital anomalies in pregnant users of non-steroidal antiinflammatory drugs: A nested case-control study. Birth Defects Res. B. Dev. Reprod. Toxicol., 2006, 77(4), 268-279. (Pubitemid 44484020)
7. Olesen, C.; Steffensen, F.H.; Nielsen, G.L.; de Jong-van den Berg, L.; Olsen, J.; Sørensen, H.T. Drug use in first pregnancy and lactation: a population-based survey among Danish women. The EUROMAP group. Eur. J. Clin. Pharmacol., 1999, 55, 139-144. (Pubitemid 29196267)
8. Ericson, A.; Källén, BA. Nonsteroidal anti-inflammatory drugs in early pregnancy. Reprod. Toxicol., 2001, 15(4), 371-375. (Pubitemid 32758390)
9. Antonucci, R.; Cuzzolin, L.; Arceri, A.; Fanos, V. Urinary prostaglandin E2 in the newborn and infant. Prostaglandins Other Lipid Mediat., 2007, 84, 1-13.
10. Chandrasekharan, N.V.; Dai, H.; Roos, K.L.; Evanson, N.K.; Tomsik, J.; Elton, T.S.; Simmons, D.L. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure and expression. Proc. Natl. Acad. Sci., 2002, 99, 13926-13931. (Pubitemid 35215482)
11. Picot, D.; Loll, P.J.; Garavito, R.M. The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1. Nature, 1994, 367(6460), 243-249. (Pubitemid 24051139)
12. Vane, J.R. Introduction: mechanism of action of NSAIDS. Br. J. Rheumatol., 1996, 35(Suppl l), l-3.
13. Luong, C.; Miller, A.; Barnett, J.; Chow, J.; Ramesha, C.; Browner, M.F. Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2. Nat. Struct. Biol., 1996, 3, 927-933. (Pubitemid 26398325)
14. Vane, J.R. Inhibition of prostaglandin synthesis as a mechanisms of action for the aspirin-like drugs. Nature, 1971, 231, 232-235.
15. Roth, G.J.; Stanford, N.; Majerus, P.W. Acetylation of prostaglandin synthetase by aspirin. Proc. Natl. Acad. Sci. U S A, 1975, 72, 3073-3076.
16. Pillinger, M.H.; Capodici, C.; Rosenthal, P.; Kheterpal, N.; Hanft, S.; Philips, M.R.; Weissman, G. Modes of action of aspirin-like drugs: Salicylates inhibit Erk activation and integrin-dependent neutrophil adhesion. Proc. Natl. Acad. Sci. U S A, 1998, 95, 14540- 14545. (Pubitemid 28549403)
17. Díaz-Gonźlez, F.; Gonźlez-Alvaro, I.; Campanero, M.R.; Mollinedo, F.; del Pozo, M.A.; Munoz, C.; Pivel, J.P.; Sinchez-Madrid, F. Prevention of in vitro neutrophil-endothelial attachment through shedding of L-selectin by nonsteroidal antiinflammatory drugs. J. Clin. Invest., 1995, 95, 1756-1765.
18. Nathan, C.; Xie, Q.W. Nitric oxide synthases: roles, tolls, and controls. Cell, 1994, 78(6), 915-918. (Pubitemid 24292319)
19. Schmidt, H.H.; Walter, U. NO at work. Cell , 1994, 78, 919-925. (Pubitemid 24292320)
20. Hawkey, C.J. Future treatments for arthritis: new NSAIDs, NO NSAIDs, or no NSAIDs? Gastroenterology, 1995, 109, 614-616.
21. Amin, A.R.; Vyas, P.; Attur, M.; Leszczynska-Pizlak, J; Patelt, I.R.; Weissmann, G; Abramson, S.B. The mode of action of aspirin- like drugs: effect on inducible nitric oxide synthase. Proc. Natl. Acad. Sci. U.S. A., 1995, 92, 7926-7930.
22. Suleyman, H.; Halici, Z.; Cadirci, E.; Hacimuftuoglu, A.; Bilen, H. Indirect role of beta2-adrenergic receptors in the mechanism of anti-inflammatory action of NSAIDs. J. Physiol. Pharmacol., 2008, 59(4), 661-672.
23. Skinner, K.A.; Challis, J.R.G. Changes in the synthesis and metabolism of prostaglandins by human fetal membranes and decidua at labour. Am. J. Obstet. Gynecol., 1985, 151, 519-523. (Pubitemid 15237606)
24. Hirst, J.J.; Teixeira, F.J.; Zakar, T.; Olson, D.M. Prostaglandin endoperoxide-H synthase-2 expression increases in human gestational tissues with spontaneous labour onset. Reprod. Fertil. Dev., 1995, 7, 633-637.
25. Slater, D.M.; Berger, L.; Newton, R.; Moore, G.E.; Bennett, P.R. Expression of cyclo-oxygenase types-1 and 2 in human fetal membranes at term. Am. J. Obstet. Gynecol., 1995, 172, 77-82.
26. Slater, D.M.; Dennes, W.J.B.; Campa, J.S.; Poston, L.; Bennett, P.R. Expression of cyclo-oxygenase types-1 and -2 in human myometrium throughout pregnancy. Mol. Hum. Reprod., 1999, 5, 880-884. (Pubitemid 29406753)
27. Smieja, Z.; Zakar, T.; Waton, J.C.; Olson, D.M. Prostaglandin endoperoxide synthase kinetics in human amnion before and after labour at term and following preterm labour. Placenta, 1993, 14, 163-175. (Pubitemid 23136259)
28. King, J.; Flenady ,V.; Cole, S.; Thornton, S. Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane database syst. rev., 2005, 2, 18, CD001992.
29. Haas, D.M.; Imperiale, T.F.; Kirkpatrick, P.R.; Klein, R.W.; Zollinger, T.W.; Golichowski, A.M. Tocolytic therapy: a metaanalysis and decision analysis. Obstet. Gynecol., 2009, 113(3), 585- 594.
30. Keirse, M.J.N.C. Indomethacin tocolysis in preterm labor. In: Pregnancy and Childbirth Module "Cochrane Database of Systemic reviews" Review 04383, 14 August 1992. Enkin, M.W.; Keirse, M.J.N.C.; Renfrew, M.J.; Neilson, J.P. Eds.; Oxford: Cochrane Updates on Disk. Update software, 1994, disk issue 1.
31. Moise, K.J. Jr; Ou, C.N.; Kirshon, B.; Cano, L.E.; Rognerud, C.; Carpenter, R.J. Jr. Placental transfer of indomethacin in the human pregnancy. Am. J. Obstet. Gynecol., 1990, 162, 549-554. (Pubitemid 20068538)
32. Vermillion, S.T.; Newman, R.B. Recent indomethacin tocolysis is not associated with neonatal complications in preterm infants. Am. J. Obstet. Gynecol., 1999, 181(5 Pt 1), 1083-1086.
33. Panter, K.R.; Hannah, M.E.; Amankwah, K.S.; Ohlsson, A.; Jefferies, A.L.; Farine, D. The effect of indomethacin tocolysis in preterm labour on perinatal outcome: a randomised placebo-controlled trial. BJOG., 1999, 106, 467-473. (Pubitemid 29201527)
34. Stika, C.S.; Gross, G.A.; Leguizamon, G.; Gerber, S.; Levy, R.; Mathur, A.; Bernhard, L.M.; Nelson, D.M.; Sadovsky, Y. A prospective randomized safety trial of celecoxib for treatment of preterm labor. Am. J. Obstet. Gynecol., 2002, 187, 653-660.
35. Kramer, W.B.; Saade, G.R.; Belfort, M.; Dorman, K.; Mayes, M.; Moise, K.J. A randomized double-blind study comparing the fetal effects of sulindac to terbutaline during the management of preterm labor. Am. J. Obstet. Gynecol., 1999, 180, 396-401. (Pubitemid 29093874)
36. Poore, K.R.; Young, I.R.; Hirst, J.J. Efficacy of the selective prostaglandin synthetase type 2 inhibitor nimesulide in blocking basal prostaglandin production and delaying glucocorticoidinduced premature labor in sheep. Am. J. Obstet. Gynecol., 1999, 180, 1243- 1253.
37. Loudon, J.A.; Groom, K.M.; Bennett, P.R. Prostaglandin inhibitors in preterm labour. Best Pract. Res. Clin. Obstet. Gynaecol., 2003, 17, 731-744. (Pubitemid 37173372)
38. Abou-Ghannam,G.; Usta, I.M.; Nassar, A.H. Indomethacin in pregnancy: applications and safety. Am. J. Perinatol., 2011 Jul 22. [Epub ahead of print]
39. Stika, C.S.; Frederiksen, M.C. Drug Therapy in Pregnant and Nursing Women. In: Atkinson, A.J.; Daniels, C.E.; Dedrick, R.L.; Grudzinskas, C.V.; Markey, S.P. (eds). Principles of Clinical Pharmacology. Academic Press: London, 2001, 278-292.
40. Tsatsaris, V.; Cabrol, D.; Carbonne, B. Pharmacokinetics of tocolytic agents. Clin. Pharmacokinet., 2004, 43(13), 833-844. (Pubitemid 39447030)
41. Syme, M.R.; Paxton, J.W.; Keelan, J.A. Drug transfer and metabolism by the human placenta. Clin. Pharmacokinet., 2004, 43, 487- 514. (Pubitemid 38858303)
42. Hill, M.D.; Abramson, F.P. The significance of plasma protein binding on the foetal/maternal distribution of drugs at steady-state. Clin. Pharmacokinet., 1988, 14, 156-170.
43. Hakkola, J.; Raunio, H.; Purkunen, R.; Pelkonen O.; Saarikoski, S.; Cresteil, T.; Pasanen, M. Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy. Biochem. Pharmacol., 1996, 52, 379-383. (Pubitemid 26233768)
44. Hakkola, J.; Pasanen, M.; Hukkanen, J.; Pelkonen, O.; Mäenpää, J.; Edwards, R.J.; Boobis, A.R.; Raunio, H. Expression of xenobioticmetabolising cytochrome P450 forms in human full-term placenta. Biochem. Pharmacol., 1996, 51, 403-411. (Pubitemid 26071173)
45. Collier, A.C.; Ganley, N.A.; Tingle, M.D.; Blumenstein, M.; Marvin, K.W.; Paxton, J.W.; Mitchell, M.D.; Keelan, J.A. UDPglucurosyltransferase activity, expression and cellular localization in human palcenta at term. Biochem. Pharmacol., 2002, 63, 409- 419. (Pubitemid 34169721)
46. Jacobson, R.L.; Brewer, A.; Eis, A.; Siddiqi, T.A. ; Myatt, L. Transfer of aspirin across the perfused human placental cotyledon. Am. J. Obstet. Gynecol., 1991, 165, 939-944.
47. Siu, S.S.; Yeung, J.H.; Lau, T.K. An in-vivo study on placental transfer of naproxen in early human pregnancy. Hum. Reprod., 2002, 17, 1056-1059. (Pubitemid 34411145)
48. Siu, S.S.; Yeung, J.H.; Lau, T.K. A study on placental transfer of diclofenac in first trimester of human pregnancy. Hum. Reprod., 2000, 15, 2423-2425.
49. Lampela, E.S.; Nuutinen, L.H.; Ala-Kokko, T.I.; Parikka, R.M.; Laitinen, R.S.; Jouppila, P.I.; Vähäkangas, K.H. Placental transfer of sulindac, sulindac sulfide, and indomethacin in a human placental perfusion model. Am. J. Obstet. Gynecol., 1999, 180(1 Pt 1), 174-180. (Pubitemid 29088411)
50. Leonhardt, A.; Bernert, S.; Watzer, B.; Schmitz-Ziegler, G.; Seyberth, H.W. Low-dose aspirin in pregnancy: maternal and neonatal aspirin concentrations and neonatal prostanoid formation. Pediatrics, 2003, 111, e77-81.
51. Macones, G.A.; Marder, S.J.; Clothier, B.; Stamilio, D.M. The controversy surrounding indomethacin for tocolysis. Am. J. Obstet. Gynecol., 2001, 184, 264-272. (Pubitemid 32206969)
52. Kramer, W.B.; Saade, G.; Ou, C.N.; Rognerud, C.; Dorman, K.; Mayes, M.; Moise, K.J. Placental transfer of sulindac and its active sulfide metabolite in humans. Am. J. Obstet. Gynecol., 1995, 172, 886-890.
53. Briggs, G.G.; Freeman, R.K.; Yaffe, S.J. Drugs in Pregnancy and Lactation. 6th edition. Philadelphia: Lippincott Williams & Wilkins; 2002. (eds).
54. Damase-Michel, C.; Christaud, J.; Berrebi, A.; Lacroix, I.; Montastruc, J.L. What do pregnant women know about non-steroidal anti-inflammatory drugs? Pharmacoepidemiol. Drug Saf., 2009, 18(11), 1034-1038.
55. østensen, M. Antirheumatic therapy and reproduction. The influence on fertility, pregnancy and breast feeding. Z. Rheumatol., 2006, 65(3), 217-20, 222-224. German.
56. Auer, M.; Brezinka, C.; Eller, P.; Luze, K.; Schweigmann, U.; Schwärzler, P. Prenatal diagnosis of intrauterine premature closure of the ductus arteriosus following maternal diclofenac application. Ultrasound Obstet. Gynecol., 2004, 23(5), 513-516. (Pubitemid 38639533)
57. Major, C.A.; Lewis, D.F.; Harding, J.A.; Porto, M.A.; Garite, T.J. Tocolysis with indomethacin increases the incidence of necrotizing enterocolitis in the low-birth-weight neonate. Am. J. Obstet. Gynecol., 1994, 170, (1 Pt 1), 102-106. (Pubitemid 24084039)
58. Ojala, R.; Ikonen, S.; Tammela, O. Perinatal indomethacin treatment and neonatal complications in preterm infants. Eur. J. Pediatr., 2000, 159(3), 153-155. (Pubitemid 30139938)
59. Amin, S.B.; Sinkin, R.A.; Glantz, J.C. Metaanalysis of the effect of antenatal indomethacin on neonatal outcomes. Am. J. Obstet. Gynecol., 2007, 197, 486.e, 1-10.
60. Montenegro, M.A.; Palomino, H. Induction of cleft palate in mice by inhibitors of prostaglandin synthesis. J. Craniofac. Genet. Dev. Biol., 1990, 10(1), 83-94. (Pubitemid 20331972)
61. Burdan, F.; Bezek, A. Current opinions on embryotoxic and teratogenic effects of ibuprofen]. Pol. Merkur. Lekarski, 2001, 11(63), 266-270. Polish.
62. Nielsen, G.L.; Sørensen, H.T.; Larsen, H.; Pedersen, L. Risk of adverse birth outcome and miscarriage in pregnant users of nonsteroidal anti-inflammatory drugs: population based observational study and case-control study. BMJ, 2001, 322, 266-270. (Pubitemid 32178552)
63. Li, D.K.; Liu, L.; Odouli, R. Exposure to non-steroidal antiinflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ, 2003, 327(7411), 368.
64. Dawood, M.Y. Nonsteroidal antiinflammatory drugs and reproduction. Am. J. Obstet. Gynecol., 1993, 169, 1255-1265. (Pubitemid 24001650)
65. Van der Weiden, R.M.; Helmerhorst, F.M.; Keirse, M.J. Influence of prostaglandins and platelet activating factor on implantation. Hum. Reprod., 1991, 6, 436-442.
66. Van der Weiden, R.M.; Helmerhorst, F.M.; Keirse, M.J. Prostanoid excretion in incipient singleton and twin pregnancies. Am. J. Obstet. Gynecol., 1996, 174, 1614-1617. (Pubitemid 26165288)
67. Van der Weiden, R.M.; Wouters, J.M. Infertility may sometimes be associated with non-steroidal anti-inflammatory drug consumption. Br. J. Rheumatol., 1997, 36, 605.
68. Caruso, A.; De Carolis, S.; Di Simone, N. Antiphospholipid antibodies in obstetrics: new complexities and sites of action. Hum. Reprod., 1999, 5, 267-276. (Pubitemid 29271965)
69. Van Dorp, D.R.; Malleis, J.M.; Sullivan, B.P.; Klein, M.D. Teratogens inducing congenital abdominal wall defects in animal models. Pediatr. Surg. Int., 2010, 26, 127-139.
70. Hoyme, H.E.; Higginbottom, M.C.; Jones, K.L. The vascular pathogenesis of gastroschisis: intrauterine interruption of the omphalomesenteric artery. J. Pediatr., 1981, 98, 228-331.
71. Burdan, F.; Szumilo, J.; Dudka, J.; Korobowicz, A.; Klepacz, R. Celosomy is associated with prenatal exposure to cyclooxygenase inhibitors. Pharmacol. Res., 2006, 53, 287-292. (Pubitemid 43247542)
72. Cappon, G.D.; Cook, J.C.; Hurtt, M.E. Relationship between cyclooxygenase 1 and 2 selective inhibitors and fetal development when administered to rats and rabbits during the sensitive periods for heart development and midline closure. Birth Defects Res. B. Dev. Reprod. Toxicol., 2003, 68(1), 47-56. (Pubitemid 37248103)
73. Drongowski, R.A.; Smith, R.K. Jr.; Coran, A.G.; Klein, M.D. Contribution of demographic and environmental factors to the etiology of gastroschisis: a hypothesis. Fetal Diagn. Ther., 1991, 6, 14-27.
74. Werler, M.M.; Mitchell, A.A.; Shapiro, S. First trimester maternal medication use in relation to gastroschisis. Teratology, 1992, 45, 361-367.
75. Torfs, C.P.; Katz, E.A.; Bateson, T.F.; Lam, P.K.; Curry C.J. Maternal medications and environmental exposures as risk factors for gastroschisis. Teratology, 1996, 54, 84-92. (Pubitemid 26421333)
76. Martínez-Frías, M.L.; Rodríguez-Pinilla, E.; Prieto, L. Prenatal exposure to salicylates and gastroschisis: a case-control study. Teratology, 1997, 56(4), 241-243. (Pubitemid 28017634)
77. Werler, M.M.; Sheehan, J.E.; Mitchell, A.A. Maternal medication use and risks of gastroschisis and small intestinal atresia. Am. J. Epidemiol., 2002, 155, 26-31. (Pubitemid 34042429)
78. Werler, M.M.; Mitchell, A.A.; Moore, C.A.; Honein, M.A. Is there epidemiologic evidence to support vascular disruption as a pathogenesis of gastroschisis? National Birth Defects Prevention Study. Am. J. Med. Genet. A., 2009, 149A, 1399-1406.
79. Cleves, M.A.; Savell, V.H. Jr; Raj, S.; Zhao, W.; Correa, A.; Werler, M.M.; Hobbs, C.A. Maternal use of acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), and muscular ventricular septal defects. Birth Defects Res. A. Clin. Mol. Teratol., 2004, 70, 107-113. (Pubitemid 38524587)
80. Kallen, B.A.; Otterblad O.P. Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod. Toxicol., 2003, 17, 255- 261. (Pubitemid 36626946)
81. Burdan, F. Comparison of developmental toxicity of selective and non-selective cyclooxygenase-2 inhibitors in CRL:(WI)WUBR Wistar rats-DFU and piroxicam study. Toxicology, 2005, 211(1-2), 12-25. (Pubitemid 40603623)
82. Cook, J.C.; Jacobson, C.F.; Gao, F.; Tassinari, M.S.; Hurtt, M.E.; DeSesso, J.M. Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits. Birth Defects Res. B. Dev. Reprod. Toxicol., 2003, 68, 5-26. (Pubitemid 37248100)
83. Burdan, F.; Szumilo, J.; Dudka, J.; Korobowicz, A.; Klepacz, R. Congenital ventricular septal defects and prenatal exposure to cyclooxygenase inhibitors. Braz. J. Med. Biol. Res., 2006, 39(7), 925- 934. (Pubitemid 44111061)
84. DeSesso, J.M. Comparative embryology. In: Handbook of Developmental Toxicology. Hood, R.D. Ed.; CRS Press: New York, 1997; pp. 117-174.
85. Engle WA; American Academy of Pediatrics Committee on Fetus and Newborn. Age terminology during the perinatal period. Pediatrics, 2004, 114(5), 1362-1364.
86. Stanfield, K.M.; Bell, R.R.; Lisowski, A.R.; English, M.L.; Saldeen, S.S.; Khan, K.N. Expression of cyclooxygenase-2 in embryonic and fetal tissues during organogenesis and late pregnancy. Birth Defects Res. A. Clin. Mol. Teratol., 2003, 67, 54-58. (Pubitemid 37238072)
87. Ferencz, C.; Loffredo, C.A.; Correa-Villasen̈or, A.; Wilson, P.D. Ventricular septal defects. In: Genetic and enviromental risk factors of major cardiovascular malformations: The Baltimore- Washington Infant Study 1981-1989.; Ferencz, C.; Loffredo, CA.; Correa-Villasen̈or, A.; Wilson, P.D. Eds., Futura Publishing Company Inc.: Armonk, 1997, pp. 123-163.
88. Briggs, G.G.; Freeman, R.K.; Yaffe, S.J. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk; Williams & Wilkins: Baltimore, 1998.
89. Burdan, F.; Sykut, J.; Przybylski, P. Developmental toxicity of naproxen. Pol. Merkur. Lekarski, 2007, 23(134), 155-158. Polish.
90. Tikkanen, J.; Heinonen, O.P. Risk factors for ventricular septal defect in Finland. Public Health, 1991, 105(2), 99-112.
91. Werler, M.M.; Mitchell, A.A.; Shapiro, S. The relation of aspirin use during the first trimester of pregnancy to congenital cardiac defects. N. Engl. J. Med., 1989, 321, 1639-1642. (Pubitemid 20012915)
92. Botto, L.D.; Lynberg, M.C.; Erickson, J.D. Congenital heart defects, maternal febrile illness, and multivitamin use: a populationbased study. Epidemiology, 2001, 12, 485-490. (Pubitemid 32761985)
93. Mirkes, P.E.; Cornel, L.M.; Park, H.W.; Cunningham, M.L. Induction of thermotolerance in early postimplantation rat embryos is associated with increased resistance to hyperthermia-induced apoptosis. Teratology, 1997, 56, 210-219. (Pubitemid 27489971)
94. Watanabe, M.; Jafri, A.; Fisher, S.A. Apoptosis is required for the proper formation of the ventriculo-arterial connections. Dev. Biol., 2001, 240, 274-288. (Pubitemid 33141124)
95. Van Overmeire, B.; Chemtob, S. The pharmacologic closure of the patent ductus arteriosus. Semin. Fetal Neonatal Med., 2005, 10(2), 177-184. (Pubitemid 40215544)
96. Coceani, F. Control of the ductus arteriosus: a new function for cytochrome P450, endothelin and nitric oxide. Biochem. Pharmacol., 1994, 48, 1315-1318. (Pubitemid 24318133)
97. Momma, K.; Takeuchi, H. Constriction of the ductus arteriosus by non-steroidal anti-inflammatory drugs. Prostaglandins, 1983, 26, 631-643. (Pubitemid 14207805)
98. Locatelli, A.; Vergani, P.; Bellini, P.; Strobelt, N.; Ghidini, A Can a cyclooxygenase type-2 selective tocolytic agent avoid the fetal side effects of indomethacin? BJOG, 2001, 108, 325-326 (Pubitemid 32210135)
99. Momma, K.; Hagiwara, H.; Konishi, T. Constriction of fetal ductus arteriosus by non-steroidal anti-inflammatory drugs: study of additional 34 drugs. Prostaglandins, 1984, 28(4), 527-536. (Pubitemid 15208265)
100. Rein, A.J.; Nadjari, M.; Elchalal, U.; Nir, A. Contraction of the fetal ductus arteriosus induced by diclofenac. Case report. Fetal Diagn. Ther., 1999, 14(1), 24-25. (Pubitemid 29206421)
101. Paladini, D.; Marasini, M.; Volpe, P. Severe ductal constriction in the third-trimester fetus following maternal self-medication with nimesulide. Ultrasound Obstet. Gynecol., 2005, 25(4), 357-361. (Pubitemid 40547177)
102. Moise, K.J. Jr. Effect of advancing gestational age on the frequency of fetal ductal constriction in association with maternal indomethacin use. Am. J. Obstet. Gynecol., 1993, 168(5), 1350-1353. (Pubitemid 23153270)
103. Coceani, F.; Huhtanen, D.; Hamilton, N.C.; Bishai, I.; Olley, P.M. Involvement of intramural prostaglandin E2 in prenatal patency of the lamb ductus arteriosus. Can. J. Physiol. Pharmacol., 1986, 64(6), 737-744. (Pubitemid 16046248)
104. Takizawa, T.; Ikeda, Y.; Kawahata, M.; Togashi, H.; Yamamoto, M.; Arishima, K.; Masaoka, T. Increased Ductal Responsiveness to PGE2 after Maternal Treatment with Aspirin and Ibuprofen. J. Vet. Med. Sci., 1998, 60(3), 377-379. (Pubitemid 128529416)
105. James, A.H.; Brancazio, L.R. Aspirin and reproductive outcomes. Obstet. Gynecol. Surv., 2008, 63(1), 49-57. (Pubitemid 351619341)
106. Huhta, J.C.; Moise, K.J.; Fisher, D.J.; Sharif, D.S.; Wasserstrum, N.; Martin, C. Detection and quantitation of constriction of the fetal ductus arteriosus by Doppler echocardiography. Circulation, 1987, 75, 406-412. (Pubitemid 17007348)
107. Gewillig, M.; Brown, S.C.; De Catte, L.; Debeer, A.; Eyskens, B.; Cossey, V.; Van Schoubroeck, D.; Van Hole, C.; Devlieger, R. Premature foetal closure of the arterial duct: clinical presentations and outcome. Eur. Heart. J., 2009, 30, 1530-1536.
108. Vermillion, S.T.; Scardo, J.A.; Lashus, A.G.; Wiles, H.B. The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age. Am. J. Obstet. Gynecol., 1997, 177, 256-261. (Pubitemid 27385699)
109. Van Den Veyver, I.B.; Moise, K.J. Jr.; Ou, C.N.; Carpenter, R.J. Jr. The effect of gestational age and fetal indomethacin levels on the incidence of constriction of the fetal ductus arteriosus. Obstet. Gynecol., 1993, 82, 500-503. (Pubitemid 23278246)
110. Tulzer, G.; Gudmundsson, S.; Sharkey, A.M.; Wood, D.C.; Cohen, A.W.; Huhta, J.C. Doppler echocardiography of fetal ductus arteriosus constriction versus increased right ventricular output. J. Am. Coll. Cardiol., 1991, 18, 532-536.
111. Tarcan, A.; Gürakan, B.; Yildirim, S.; Ozkiraz, S.; Bilezikçi, B. Persistent pulmonary hypertension in a premature newborn after 16 hours of antenatal indomethacin exposure. J. Perinat. Med., 2004, 32(1), 98-99. (Pubitemid 38292643)
112. Baerts, W.; Fetter, W.P.; Hop, W.C; Wallenburg, H.C.; Spritzer, R.; Sauer, P.J. Cerebral lesions in preterm infants after tocolytic indomethacin. Dev. Med. Child. Neurol., 1990, 32, 910-918. (Pubitemid 20310737)
113. Loe, S.M.; Sanchez-Ramos, L.; Kaunitz, A.M. Assessing the neonatal safety of indomethacin tocolysis: a systematic review with meta-analysis. Obstet. Gynecol., 2005, 106(1), 173-179. (Pubitemid 40898451)
114. Abbasi, S.; Gerdes, J.S.; Sehdev, H.M.; Samimi, S.S.; Ludmir, J. Neonatal outcome after exposure to indomethacin in utero: a retrospective case cohort study. Am. J. Obstet. Gynecol., 2003, 189, 782-785. (Pubitemid 37194105)
115. Doyle, N.M.; Gardner, M.O.; Wells, L.; Qualls, C.; Papile, L.A. Outcome of very low birth weight infants exposed to antenatal indomethacin for tocolysis. J. Perinatol., 2005, 25, 336-340. (Pubitemid 40645605)
116. Norton, M.E.; Merrill, J.; Cooper, B.A.; Kuller, J.A.; Clyman, R.I. Neonatal complications after the administration of indomethacin for preterm labor. N. Engl. J. Med., 1993, 329(22), 1602-1607. (Pubitemid 23345638)
117. Hammerman, C.; Glaser, J.; Kaplan, M.; Schimmel, M.S.; Ferber, B.; Eidelman, A.I. Indomethacin tocolysis increases postnatal patent ductus arteriosus severity. Pediatrics, 1998, 102, E56.
118. Clyman, R.I.; Chen, Y.Q.; Chemtob, S.; Mauray, F.; Kohl, T.; Varma, D.R.; Roman, C. In utero remodeling of the fetal lamb ductus arteriosus: the role of antenatal indomethacin and avascular zone thickness on vasa vasorum proliferation, neointima formation, and cell death. Circulation, 2001, 103(13), 1806-1812. (Pubitemid 32291420)
119. Reese, J.; Anderson, J.D.; Brown, N.; Roman, C.; Clyman, R.I. Inhibition of cyclooxygenase isoforms in late- but not midgestation decreases contractility of the ductus arteriosus and prevents postnatal closure in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2006, 291, R1717-R1723. (Pubitemid 44904139)
120. Loftin, C.D.; Trivedi, D.B.; Tiano, H.F.; Clark, J.A.; Lee, C.A.; Epstein, J.A.; Morham, S.G.; Breyer, M.D.; Nguyen, M.; Hawkins, B.M.; Goulet, J.L.; Smithies, O.; Koller, B.H.; Langenbach, R. Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2. Proc. Natl. Acad. Sci. U S A, 2001, 98, 1059-1064. (Pubitemid 32121186)
121. Momma, K.; Toyoshima, K.; Ito, K.; Sugiyama, K.; Imamura, S.; Sun, F.; Nakanishi, T. Delayed neonatal closure of the ductus arteriosus following early in utero exposure to indomethacin in the rat. Neonatology, 2009, 96, 69-79.
122. Reese, J.; Paria, B.C.; Brown, N.; Zhao, X.; Morrow, J.D.; Dey, S.K. Coordinated regulation of fetal and maternal prostaglandins directs successful birth and postnatal adaptation in the mouse. Proc. Natl. Acad. Sci. U S A, 2000, 97, 9759-9764. (Pubitemid 30650849)
123. Baragatti, B.; Brizzi, F.; Ackerley, C.; Barogi, S.; Ballou, L.R.; Coceani, F. Cyclooxygenase- 1 and cyclooxygenase-2 in the mouse ductus arteriosus: individual activity and functional coupling with nitric oxide synthase. Br. J. Pharmacol., 2003, 139, 1505-1515. (Pubitemid 37174665)
124. Yokoyama, U.; Minamisawa, S.; Quan, H.; Ghatak, S.; Akaike, T.; Segi-Nishida, E.; Iwasaki, S.; Iwamoto, M.; Misra, S.; Tamura, K.; Hori, H.; Yokota, S.; Toole, B.P.; Sugimoto, Y.; Ishikawa, Y. Chronic activation of the prostaglandin receptor EP4 promotes hyaluronan- mediated neointimal formation in the ductus arteriosus. J. Clin. Invest., 2006, 116, 3026-3034. (Pubitemid 44684487)
125. Clyman, R.I.; Waleh, N.S.; Kajino, H.; Roman, C.; Mauray, F. Calcium-dependent and calcium-sensitizing pathways in the mature and immature ductus arteriosus. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2007, 293, R1650-R1656. (Pubitemid 47535783)
126. Nakanishi, T.; Gu, H.; Hagiwara, N.; Momma, K. Mechanisms of oxygen-induced contraction of ductus arteriosus isolated from the fetal rabbit. Circ. Res., 1993, 72, 1218- 1228. (Pubitemid 23147605)
127. Tristani-Firouzi, M.; Reeve, H.L.; Tolarova, S.; Weir, E.K.; Archer, S.L. Oxygeninduced constriction of rabbit ductus arteriosus occurs via inhibition of a 4-aminopyridine-, voltage-sensitive potassium channel. J. Clin. Invest., 1996, 98, 1959-1965. (Pubitemid 26376282)
128. Thebaud, B.; Michelakis, E.D.; Wu, X.C.; Moudgil, R.; Kuzyk, M.; Dyck, J.R.; Harry, G.; Hashimoto, K.; Haromy, A.; Rebeyka, I.; Archer, S.L. Oxygen-sensitive Kv channel gene transfer confers oxygen responsiveness to preterm rabbit and remodeled human ductus arteriosus: implications for infants with patent ductus arteriosus. Circulation, 2004, 110, 1372-1379. (Pubitemid 39238014)
129. Thebaud, B.; Wu, X.C.; Kajimoto, H.; Bonnet, S.; Hashimoto, K.; Michelakis, E.D.; Archer, S.L. Developmental absence of the O2 sensitivity of L-type calcium channels in preterm ductus arteriosus smooth muscle cells impairs O2 constriction contributing to patent ductus arteriosus. Pediatr. Res., 2008, 63, 176-181.
130. Kajimoto, H.; Hashimoto, K.; Bonnet, S.N.; Haromy, A.; Harry, G.; Moudgil, R.; Nakanishi, T.; Rebeyka, I.; Thebaud, B.; Michelakis, E.D.; Archer, S.L. Oxygen activates the Rho/Rhokinase pathway and induces RhoB and ROCK-1 expression in human and rabbit ductus arteriosus by increasing mitochondriaderived reactive oxygen species. A newly recognized mechanism for sustaining ductal constriction. Circulation, 2007, 115, 1777- 1788. (Pubitemid 46648615)
131. Hong, Z.; Hong, F.; Olschewski, A.; Cabrera, J.A.; Varghese, A.; Nelson, D.P.; Weir, E.K. Role of store-operated calcium channels and calcium sensitization in normoxic contraction of the ductus arteriosus. Circulation, 2006, 114,1372-1379. (Pubitemid 44454557)
132. Costa, M.; Barogi, S.; Socci, N.D.; Angeloni, D.; Maffei, M.; Baragatti, B.; Chiellini, C.; Grasso, E.; Coceani, F. Gene expression in ductus arteriosus and aorta: comparison of birth and oxygen effects. Physiol. Genomics, 2006, 25, 250-262.
133. Kim, H.S.; Aikawa, M.; Kimura, K.; Kuro-o, M.; Nakahara, K.; Suzuki, T.; Katoh, H.; Okamoto, E.; Yazaki, Y.; Nagai, R. Ductus arteriosus. Advanced differentiation of smooth muscle cells demonstrated by myosin heavy chain isoform expression in rabbits. Circulation, 1993, 88, 1804-1810.
134. Slomp, J.; Gittenberger-de Groot, A.C.; Glukhova, M.A.; Conny van Munsteren, J.; Kockx, M.M.; Schwartz, S.M.; Koteliansky, V.E. Differentiation, dedifferentiation, and apoptosis of smooth muscle cells during the development of the human ductus arteriosus. Arterioscler. Thromb. Vasc. Biol., 1997, 17, 1003-1009. (Pubitemid 27209281)
135. Morano, I.; Chai, G.X.; Baltas, L.G.; Lamounier-Zepter, V.; Lutsch, G.; Kott, M.; Haase, H.; Bader, M. Smooth-muscle contraction without smooth-muscle myosin. Nat. Cell. Biol., 2000, 2, 371-375.
136. Huang, J.; Cheng, L.; Li, J.; Chen, M.; Zhou, D.; Lu, M.M.; Proweller, A.; Epstein, J.A.; Parmacek, M.S. Myocardin regulates expression of contractile genes in smooth muscle cells and is required for closure of the ductus arteriosus in mice. J. Clin. Invest., 2008, 118, 515-525. (Pubitemid 351206542)
137. Takizawa, T.; Oda, T.; Arishima, K.; Yamamoto, M.; Masaoka, T.; Somiya, H.; Akahori, F.; Shiota, K. A calcium channel blocker verapamil inhibits the spontaneous closure of the ductus arteriosus in newborn rats. J. Toxicol. Sci., 1994, 19, 171-174. (Pubitemid 24295843)
138. Reese, J.; Waleh, N.; Poole, S.D.; Brown, N.; Roman, C.; Clyman, R.I. Chronic in utero cyclooxygenase inhibition alters PGE2- regulated ductus arteriosus contractile pathways and prevents postnatal closure. Pediatr. Res, 2009, 66, 155-161.
139. Philips, J.B.; Lyrene, R.K. Prostaglandins, related compounds, and the perinatal pulmonary circulation. Clin. Perinatol., 1984, 11, 565-579. (Pubitemid 14017906)
140. Manchester, D.; Margolis, H.S.; Sheldon, R.E. Possible association between maternal indomethacin therapy and primary pulmonary hypertension of the newborn. Am. J. Obstet. Gynecol., 1976, 126, 467-469.
141. Levin, D.L.; Mills, L.J.; Weinberg A.G. Hemodynamic, pulmonary vascular, and myocardial abnormalities secondary to pharmacologic constriction of the fetal ductus arteriosus. A possible mechanism for persistent pulmonary hypertension and transient tricuspid insufficiency in the newborn infant. Circulation, 1979, 60(2), 360-364.
142. Wild, L.M.; Nickerson, P.A.; Morin, F.C. Ligating the ductus arteriosus before birth remodels the pulmonary vasculature of the lamb. Pediatr. Res., 1989, 25, 251-257. (Pubitemid 19086074)
143. Momma, K.; Takao, A. In vivo constriction of the ductus arteriosus by nonsteroidal antiinflammatory drugs in near term and preterm fetal rats. Pediatr. Res., 1987, 22, 567-572. (Pubitemid 18002064)
144. Heymann, M.A.; Rudolph, A.M. Effects of acetylsalicylic acid on the ductus arteriosus and circulation in fetal lambs in utero. Circ. Res., 1976, 38, 418-422.
145. Sharpe, G.L.; Larsson, K.S.; Thalme, B. Studies on closure of the ductus arteriosus. XII. In utero effect of indomethacin and sodium salicylate in rats and rabbits. Prostaglandins, 1975, 9, 585-596.
146. Harker, L.C.; Kirkpatrick, S.E.; Friedman, W.F.; Bloor, C.M. Effects of indomethacin on fetal rat lungs: a possible cause of persistent fetal circulation (PFC). Pediatr. Res., 1981, 15, 147-151. (Pubitemid 11183885)
147. Lock, J.E.; Olley, P.M.; Soldin, S.; Coceani, F. Indomethacininduced pulmonary vasoconstriction in the conscious newborn lamb. Pediatr. Res., 1980, 238, 639-644.
148. Ohara, T.; Ogata, H. Animal model of persistent pulmonary hypertension of the newborn with fetal lambs. The XXIVth Congress of the Japan Society of Neonatology, Tokyo, Japan, 1988.
149. Demello, D.E.; Murphy, J.D.; Aronovitz, M.J.; Davies, P.; Reid, L.M. Effects of indomethacin in utero on the pulmonary vasculature of the newborn Guinea pig. Pediatr. Res., 1987, 22, 693-697. (Pubitemid 18034114)
150. Ohara, T.; Ogata, H.; Tezuka, F. Effects of indomethacin in utero on the pulmonary vasculature of the newborn lambs. Tohoku J. Exp. Med., 1991, 164(1), 67-79.
151. Van Marter, L.J.; Leviton, A.; Allred, E.N.; Pagano, M.; Sullivan, K.F.; Cohen, A.; Epstein, M.F. Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy. Pediatrics, 1996, 97, 658-663. (Pubitemid 26138095)
152. Zenker, M.; Klinge, J.; Krüger, C.; Singer, H.; Scharf, J. Severe pulmonary hypertension in a neonate caused by premature closure of the ductus arteriosus following maternal treatment with diclofenac: a case report. J. Perinat. Med., 1998, 26(3), 231-234. (Pubitemid 28368022)
153. Siu, K.L.; Lee, W.H. Maternal diclofenac sodium ingestion and severe neonatal pulmonary hypertension. J. Paediatr. Child. Health, 2004, 40(3), 152-153. (Pubitemid 38446429)
154. Talati, A.J.; Salim, M.A.; Korones, S.B. Persistent pulmonary hypertension after maternal naproxen ingestion in a term newborn: a case report. Am. J. Perinatol., 2000, 17(2), 69-71.
155. French. Bouissou, A.; Glorieux, I.; Dulac, Y.; Marcoux, M.O.; Casper, C. Antenatal closure of ductus arteriosus following maternal intoxication by niflumic acid. Arch. Pediatr., 2006, 13(1), 48-50. French. (Pubitemid 43052620)
156. Joschko, M.A.; Dreosti, I.E.; Tulsi, R.S. The teratogenic effects of salicylic acid on the developing nervous system in rats in vitro. Teratology, 1993, 48(2), 105-114. (Pubitemid 23233587)
157. Elkarmi, A.; Abu-Samak, M.; Al-Qaisi, K. Modeling the effects of prenatal exposure to aspirin on the postnatal development of rat brain. Growth Dev. Aging, 2007, 70(1), 13-24. (Pubitemid 47413282)
158. Gökçimen, A.; Rabetli, M.C.; Ba, O.; Tunc, A.T.; Aslan, H.; Yazici, A.C.; Kaplan, S. Effect of prenatal exposure to an antiinflammatory drug on neuron number in cornu ammonis and dentate gyrus of the rat hippocampus: a stereological study. Brain Res., 2007, 1127(1), 185-192. (Pubitemid 44873001)
159. Ragbetli, M.C.; Ozyurt, B.; Aslan, H.; Odaci, E.; Gokcimen, A.; Sahin, B.; Kaplan, S. Effect of prenatal exposure to diclofenac sodium on Purkinje cell numbers in rat cerebellum: a stereological study. Brain Res., 2007, 1174, 130-135. (Pubitemid 47469972)
160. Odaci, E.; Cihan, O.F.; Aslan, H.; Ragbetli, M.C.; Kaplan, S. Prenatal diclofenac sodium administration increases the number of Purkinje cells in female rats: a stereological study. Int. J. Dev. Neurosci., 2010, 28(2), 145-151.
161. Marret, S.; Marchand, L.; Kaminski, M.; Larroque, B.; Arnaud, C.; Truffert, P.; Thirez, G.; Fresson, J.; Rozé, J.C.; Ancel, P.Y.; EPIPAGE Study Group. Prenatal low-dose aspirin and neurobehavioral outcomes of children born very preterm. Pediatrics, 2010, 125(1), e29-34.
162. Canan, S.; Akta, A.; Ulkay, M.B.; Colakoglu, S.; Ragbetli, M.C.; Ayyildiz, M.; Geuna, S.; Kaplan, S. Prenatal exposure to a nonsteroidal anti-inflammatory drug or saline solution impairs sciatic nerve morphology: a stereological and histological study. Int. J. Dev. Neurosc., 2008, 26(7), 733-738.
163. Wood, C.E.; Powers Fraites, M.; Keller-Wood, M. Blockade of PGHS-2 inhibits the hypothalamus-pituitary-adrenal axis response to cerebral hypoperfusion in the sheep fetus. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2009, 296(6), R1813-1819.
164. Knutson, N.; Wood, C.E. Interaction of PGHS-2 and glutamatergic mechanisms controlling the ovine fetal hypothalamus-pituitaryadrenal axis. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2010, 299(1), R365-370.
165. Tong, H.; Lakhdir, F.; Wood, C.E. Endogenous prostanoids modulate the ACTH and AVP responses to hypotension in late-gestation fetal sheep. Am. J. Physiol. Regul. Integr. Comp. Physiol., 1998, 275, R735-R741.
166. Parfenova, H.; Levine, V.; Gunther, W.M.; Pourcyrous, M.; Leffler, C.W. COX-1 and COX-2 contributions to basal and IL-1 betastimulated prostanoid synthesis in human neonatal cerebral microvascular endothelial cells. Pediatr. Res., 2002, 52, 342-348. (Pubitemid 34920262)
167. Chemtob, S.; Laudignon, N.; Beharry, K.; Rex, J.; Varma, D.; Wolfe, L.; Aranda, J.V. Effects of prostaglandins and indomethacin on cerebral blood flow and cerebral oxygen consumption of conscious newborn piglets. Dev. Pharmacol. Ther., 1990, 14(1), 1-14. (Pubitemid 20034046)
168. Pourcyrous, M.; Leffler, C.W.; Bada, H.S.; Korones, S.B.; Busija, D.W. Cerebral blood flow responses to indomethacin in awake newborn pigs. Pediatr. Res., 1994, 35(5), 565-570. (Pubitemid 24130114)
169. Li, D.Y.; Hardy, P.; Abran, D.; Martinez-Bermudez, A.K.; Guerguerian, A.M.; Bhattacharya, M.; Almazan, G.; Menezes, R.; Peri, K.G.; Varma, D.R.; Chemtob, S. Key role for cyclooxygenase-2 in PGE2 and PGF2alpha receptor regulation and cerebral blood flow of the newborn. Am. J. Physiol., 1997, 273(4 Pt 2), R1283-1290.
170. Najarian, T.; Hardy, P.; Hou, X.; Lachapelle, J., Doke, A.; Gobeil, F.jr.; Roy, M.S.; Lachapelle, P.; Varma, D.; Chemtob, S. Preservation of neural function in the perinate by high PGE2 levels acting via EP2 receptors. J. Appl. Physiol., 2000, 89, 777-784. (Pubitemid 30637129)
171. Mosca, F.; Bray, M.; Lattanzio, M.; Fumagalli, M.; Tosetto, C. Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. J. Pediatr., 1997, 131, 549-554. (Pubitemid 28006927)
172. Thomas, R.L.; Parker, G.C.; Van Overmeire, B.; Aranda, J.V. A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus. Eur. J. Pediatr., 2005, 164, 135-140. (Pubitemid 40558175)
173. Murata, Y.; Itakura, A.; Matsuzawa, K.; Okumura, A.; Wakai, K.; Mizutani, S. Possible antenatal and perinatal related factors in development of cystic periventricular leukomalacia. Brain Dev., 2005, 27, 17-21. (Pubitemid 40051299)
174. Perlman, J.M. The relationship between systemic hemodynamic perturbations and periventricular-intraventricular hemorrhage a historical perspective. Semin. Pediatr. Neurol., 2009, 16(4), 191- 199.
175. Suarez, R.D.; Grobman, W.A.; Parilla, B.V. Indomethacin tocolysis and intraventricular hemorrhage. Obstet. Gynecol., 2001, 97, 921- 925. (Pubitemid 32522489)
176. Rumack, C.M.; Guggenheim, M.A.; Rumack, B.H.; Peterson, R.G.; Johnson, M.L.; Braithwaite, W.R. Neonatal intracranial hemorrhage and maternal use of aspirin. Obstet. Gynecol., 1981, 58 (5 Suppl), 52S-56S. (Pubitemid 12163649)
177. Govaert, P.; Staelens, V.; Vanhaesebrouch, P. Perinatal intracranial hemorrhage due to maternal salicylate ingestion. Clin. Pediatr. (Phila)., 1995, 34, 174-175.
178. Shetty, S.; Ghosh, K. Anti-phospholipid antibodies and other immunological causes of recurrent foetal loss - a review of literature of various therapeutic protocols. Am. J. Reprod. Immunolog., 2009, 62, 9-24.
179. Skrzypczak, J. The management of pregnant women with antiphospholipid syndrome. Arch. Med. Wewn., 2007, 117, 50-53. Polish. (Pubitemid 350190336)
180. Parilla, B.V.; Tamura, R.K.; Cohen, L.S.; Clark, E. Lack of effect of antenatal indomethacin on fetal cerebral blood flow. Am. J. Obstet. Gynecol., 1997, 176(6), 1166-1169, discussion 1169-1171.
181. Salokorpi, T.; Eronen, M.; von Wendt, L. Growth and development until 18 months of children exposed to tocolytics indomethacin or nylidrin. Neuropediatrics, 1996, 27(4), 174-177. (Pubitemid 26319249)
182. Al-Alaiyan, S.; Seshia, M.M.; Casiro, O.G. Neurodevelopmental outcome of infants exposed to indomethacin antenatally. J. Perinat. Med., 1996, 24(4), 405-411. (Pubitemid 26278829)
183. Amin, S.B.; Kamaluddeen, M.; Sangem, M. Neurodevelopmental Outcome of Premature Infants after Exposure to Antenatal Indomethacin. Am. J. Obstet. Gynecol., 2008, 199(1), 41.e1-41.e8.
184. Macones, G.A.; Robinson, C.A. Is there justification for using indomethacin in preterm labor? An analysis of neonatal risks and benefits. Am. J. Obstet. Gynecol., 1997, 177(4), 819-824. (Pubitemid 27516048)
185. Man̈alich, R.; Reyes, L.; Herrera, M.; Melendi, C.; Fundora, I. Relationship between weight at birth and the number and size of renal glomeruli in humans: a histomorphometric study. Kidney Int., 2000, 58, 770-773. (Pubitemid 30620027)
186. Zaffanello, M.; Bassareo, P.P.; Cataldi, L.; Antonucci, R.; Biban, P.; Fanos, V. Long-term effects of neonatal drugs on the kidney. J. Matern. Fetal Neonatal Med., 2010, 23 Suppl 3, 87-89.
187. Cataldi, L.; Leone, R.; Moretti, U.; De Mitri, B.; Fanos, V.; Ruggeri, L.; Sabatino, G.; Torcasio, F.; Zanardo, V.; Attardo, G.; Riccobene, F.; Martano, C.; Benini, D.; Cuzzolin, L. Potential risk factors for the development of acute renal failure in preterm newborn infants: a case-control study. Arch. Dis. Child. Fetal Neonatal, Ed. 2005, 90(6), F514-519. (Pubitemid 41565317)
188. Boubred, F.; Vendemmia, M.; Garcia-Meric, P.; Buffat, C.; Millet, V.; Simeoni, U. Effects of maternally administered drugs on the fetal and neonatal kidney. Drug Saf., 2006, 29(5), 397-419.
189. Bavoux, F. Bavoux, F. Fetal toxicity of non-steroidal anti-inflammatory agents. Presse Med., 1992, 21(40), 1909-1912 (Pubitemid 23013279)
190. Drukker, A.; Guignard, J.P. Renal aspects of the term and preterm infant: a selective update. Curr. Opin. Pediatr., 2002, 14(2), 175- 182. (Pubitemid 34412161)
191. Cuzzolin, L.; Dal Cer, M.; Fanos, V. NSAID-induced nephrotoxicity from the fetus to the child. Drug Saf., 2001, 24(1), 9-18. (Pubitemid 32113364)
192. Robin, Y.M.; Reynaud, P.; Orliaguet, T.; Lemery, D.; Vanlieferingen, P.; Dechelotte, P. Renal tubular dysgenesis-like lesions and hypocalvaria. Report of two cases involving indomethacin. Pathol. Res. Pract., 2000, 196(11), 791-794.
193. Butler-O'Hara, M.; D'Angio, C.T. Risk of persistent renal insufficiency in premature infants following the prenatal use of indomethacin for suppression of preterm labor. J. Perinatol., 2002, 22(7), 541-546.
194. Itabashi, K.; Ohno, T.; Nishida, H. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin. J. Pediatr., 2003, 143(2), 203-207. (Pubitemid 37082952)
195. Jacqz-Aigrain, E.; Guillonneau, M.; Boissinot, C.; Bavoux, F.; Hartmann, J.F.; Blot, P. Maternal and neonatal effects of indomethacin administrated during pregnancy. Apropos of 18 cases. Arch. Fr. Pediatr., 1993, 50(4), 307-312. French. (Pubitemid 23138375)
196. van der Heijden, B.J.; Carlus, C.; Narcy, F.; Bavoux, F.; Delezoide, A.L.; Gubler, M.C. Persistent anuria, neonatal death, and renal microcystic lesions after prenatal exposure to indomethacin. Am. J. Obstet. Gynecol., 1994, 171(3), 617-623. (Pubitemid 24312339)
197. van der Heijden, B.; Gubler, M.C. Renal failure in the neonate associated with in utero exposure to non-steroidal antiinflammatory agents. Pediatr. Nephrol., 1995, 9(5), 675.
198. van der Heijden, A.J.; Provoost, A.P.; Nauta, J.; Wolff, E.D.; Sauer, P.J. Indomethacin as an inhibitor of preterm labor. Effect on postnatal renal function. Contrib. Nephrol., 1988, 67, 152-154.
199. Van Den Anker, J.N.; Hop, W.C.J.; De Groot, R.; Van Der Heijden, B.J.; Broerse, H.M.; Lindemans, J.; Sauer, P.J.J. Effects of prenatal exposure to betamethasone and indomethacin on the glomerular filtration rate in the preterm infant. Pediatr. Res., 1994, 36, 578-581. (Pubitemid 24331360)
200. Vieux, R.; Fresson, J.; Guillemin, F.; Hascoet, J.M. Perinatal drug exposure and renal function in very preterm infants. Arch. Dis. Child. Fetal Neonatal Ed., 2011, 96, 290-295.
201. George, I.; Mekahli, D.; Rayyan, M.; Levtchenko, E.; Allegaert, K. Postnatal trends in creatinemia and its covariates in extremely low birth weight (ELBW) neonates. Pediatr. Nephrol., 2011, 26, 1843- 1849.
202. Allegaert, K.; Rayyan, M.; Anderson, B.J. Impact of ibuprofen administration on renal drug clearance in the first weeks of life. Methods Find. Exp. Clin. Pharmacol., 2006, 28(8), 519-522. (Pubitemid 44885381)
203. Iacobelli, S.; Bonsante, F.; Ferdinus, C.; Labenne, M.; Gouyon, J.B. Factors affecting postnatal changes in serum creatinine in preterm infants with gestational age 32 weeks. J. Perinatol., 2009, 29(3), 232-236.
204. Antonucci, R.; Cuzzolin, L.; Arceri, A.; Dess, A.; Fanos, V. Changes in urinary PGE2 after ibuprofen treatment in preterm infants with patent ductus arteriosus. Eur. J. Clin. Pharmacol., 2009, 65(3), 223-230.
205. Benini, D.; Fanos, V.; Cuzzolin, L.; Tatò, L. In utero exposure to nonsteroidal anti-inflammatory drugs: neonatal renal failure. Pediatr. Nephrol., 2004, 19(2), 232-234. (Pubitemid 38181020)
206. Magnani, C.; Moretti, S.; Ammenti, A. Neonatal chronic renal failure associated with maternal ingestion of Nimesulide as analgesic. Eur. J. Obstet. Gynecol. Reprod. Biol., 2004, 116(2), 244-245. (Pubitemid 39195147)
207. Ali, U.S.; Khubchandani, S.; Andankar, P.; Parekhji, S.; Dubhalish, V.; Padhye, B. Renal tubular dysgenesis associated with in utero exposure to Nimuselide. Pediatr. Nephrol., 2006, 21(2), 274-276. (Pubitemid 43115884)
208. Alessandri, J.L.; Abossolo, T.; Reynaud, I.; Montbrun, A.; Sommer, J.C.; Tilmont, P. Non-steroidal anti-inflammatory agents and pregnancy. A study of renal and digestive toxicity of niflumic acid in the perinatal period. J. Gynecol. Obstet. Biol. Reprod. (Paris), 1994, 23(7), 813-818. French.
209. Voyer, L.E.; Drut, R.; Méndez, J.H. Fetal renal maldevelopment with oligohydramnios following maternal use of piroxicam. Pediatr. Nephrol., 1994, 8(5), 592-594. (Pubitemid 24287874)
210. Gouyon, J.B.; Petion, A.M.; Sandre, D.; Sgro, C.; Bavoux, F. Neonatal kidney insufficiency and intrauterine exposure to ketoprofen. Arch. Fr. Pediatr., 1991, 48(5), 347-348. French.
211. Fieni, S.; Gramellini, D.; Vadora, E. Oligohydramnios and fetal renal sonographic appearances related to prostaglandin synthetase inhibitors. A case report. Fetal Diagn. Ther., 2004, 19(3), 224-227. (Pubitemid 38469316)
212. Chen, N.; Aleksa, K.; Woodland, C.; Rieder, M.; Koren, G. Ontogeny of drug elimination by the human kidney. Pediatr. Nephrol., 2006, 21, 160-168. (Pubitemid 43115865)
213. Fanos, V.; Cataldi, L. Antibacterial-induced nephrotoxicity in the newborn. Drug. Saf., 1999, 20, 245-267. (Pubitemid 29134899)
214. Balasubramaniam, J. Nimesulide and neonatal renal failure. Lancet, 2000, 355(9203), 575. (Pubitemid 30088686)
215. Koklu, E.; Gurgoze, M.; Akgun, H.; Ozturk, M.A.; Poyrazoglu, M.H. Renal tubular dysgenesis with atypical histology and in-utero exposure to naproxen sodium. Ann. Trop. Paediatr., 2006, 26(3), 241-245. (Pubitemid 47054036)
216. Nguyen, M.T.; Devarajan, P. Biomarkers for the early detection of acute kidney injury. Pediatr. Nephrol., 2008, 23, 2151-2157.
217. Zaffanello, M.; Antonucci, R.; Cuzzolin, L.; Cataldi, L.; Fanos, V. Early diagnosis of acute kidney injury with urinary biomarkers in the newborn. J. Matern. Fetal Neonatal Med., 2009, 22(s3), 62-66.
218. Nagai, A.; Katayama, M.; Thurlbeck, W.M.; Matsui, R.; Yasui, S.; Konno, K. Effect of indomethacin on lung development in postnatal rats: possible role of prostaglandin in alveolar formation. Am. J. Physiol., 1995, 268 (1 Pt 1), L56-62.
219. Ambalavanan, N.; Walsh, M.; Bobashev, G.; Das, A.; Levine,B.; Carlo, W.A.; Higgins, R.D.; NICHD Neonatal Research Network. Intercenter differences in bronchopulmonary dysplasia or death among very low birth weight infants. Pediatrics, 2011, 127, 106- 116.
220. Eronen M.; Peesonen, E.; Kurki, T.; Teramo, K.; Ylikorkala, O.; Hallman, M. Increased incidence of bronchopolmonary dysplasia after antenatal administration of indomethacin to prevent preterm labour. J. Pediatr.,1994, 124, 782-788. (Pubitemid 24161473)
221. Ho, M.L.; Chang, J.K.; Chuang, L.Y.; Hsu, H.K.; Wang, G.J. Effects of nonsteroidal anti-inflammatory drugs and prostaglandins on osteoblastic functions. Biochem. Pharmacol., 1999, 58, 983- 990.
222. Chang, J.K.; Wang, G.J.; Tsai, S.T.; Ho, M.L. Nonsteroidal antiinflammatory drug effects on osteoblastic cell cycle, cytotoxicity, and cell death. Connect Tissue Res., 2005, 46, 200-210.
223. Chang, J.K.; Wu, S.; Wang, G.J.; Cho, M.H.; Ho, M.L. Effects of non-steroidal anti-inflammatory drugs on cell proliferation and death in cultured epiphyseal-articular chondrocytes of fetal rats. Toxicology, 2006, 228, 111-123. (Pubitemid 44708439)
224. Burdan, F.; Rozylo-Kalinowska, I.; Szumilo, J.; Dudka, J.; Klepacz, R. Cyclooxygenase inhibitors affect bone mineralization in rat fetuses. Cells Tissues Organs, 2008, 187, 221-232. (Pubitemid 351398235)
225. Burdan, F.; Szumilo, J; Klepacz, R. Maternal toxicity of nonsteroidal anti-inflammatory drugs as an important factor affecting prenatal development. Reprod. Toxicol., 2009, 28, 239-244.
226. Dimmen, S.; Nordsletten, L.; Madsen, J.E. Parecoxib and indomethacin delay early fracture healing: a study in rats. Clin. Orthop. Relat. Res., 2009, 467(8), 1992-1999.
227. Dodo, T.; Fukuta, T.; Uchida, K.; Mineshima, H.; Okuda, Y.; Okada, F.; Katsutani, N.; Hirano, K.; Aoki, T. A comparative investigation of fetal skeletal anomalies in rats induced by acetylsalicylic acid with single- and double-staining techniques. Regul. Toxicol. Pharmacol., 2009, 54(3), 308-313.
228. Attridge, J.T.; Clark, R.; Walker, M.W.; Gordon, P.V. New insights into spontaneous intestinal perforation using a national data set: (1) SIP is associated with early indomethacin exposure. J. Perinatol., 2006, 26(2), 93-99.
229. Gordon, P.V. Understanding intestinal vulnerability to perforation in the extremely low birth weight infant. Pediatr. Res., 2009, 65(2), 138-144.
230. Gordon, P.V.; Attridge, J.T. Understanding clinical literature relevant to spontaneous intestinal perforations. Am. J. Perinatol., 2009, 26, 309-316.
231. Neu, J.; Wu-Wang, C.Y. Eicosanoids in the developing gastrointestinal tract. Semin. Perinatol., 1987, 11 (1), 22-30.
232. Wallace, J.L.; Cohen, M.M. Gastric mucosal protection with chronic mild restraint: role of endogenous prostaglandins. Am. J. Physiol., 1984, 247(2 Pt 1), G127-132. (Pubitemid 14063080)
233. Peskar, B.M. On the synthesis of prostaglandins by human gastric mucosa and its modification by drugs. Biochim. Biophys. Acta, 1977, 487(2), 307-314. (Pubitemid 8091075)
234. Meyers, R.L.; Alpan, G.; Lin, E.; Clyman, R.I. Patent ductus arteriosus, indomethacin, and intestinal distension: effects on intestinal blood flow and oxygen consumption. Pediatr. Res., 1991, 29(6), 569-574.
235. Watterberg, K.L.; Jerdes, J.S.; Cole, C.H.; Aucott, S.W.; Thilo, E.H.; Mammel, M.C.; Couser, R.J.; Garland, J.S.; Rozycki, H.J.; Leach, C.L.; Backstrom, C.; Shaffer, M.L. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial. Pediatrics, 2004, 114, 1649-1657. (Pubitemid 41754933)
236. Vanhaesebrouck, P.; Thiery, M.; Leroy, J.G.; Govaert, P.; de Praeter, C.; Coppens, M.; Cuvelier, C.; Dhont, M. Oligohydramnios, renal insufficiency, and ileal perforation in preterm infants after intrauterine exposure to indomethacin. J. Pediatr., 1988, 113, 738-743.
237. Gordon, P.V.; Swanson, J.R.; Clark R. Antenatal indomethacin is more likely associated with spontaneous intestinal perforation rather than NEC. Am. J. Obstet. Gynecol., 2008, 198, 725; author reply 725-726. (Pubitemid 351758909)
238. Sharma, R.; Hudak, M.L.; Tepas, J.J. 3rd; Wludyka, P.S.; Teng, R.J.; Hastings, L.K.; Renfro, W.H.; Marvin, W.J. Jr. Prenatal or postnatal indomethacin exposure and neonatal gut injury associated with isolated intestinal perforation and necrotizing enterocolitis. J. Perinatol., 2010, 30(12), 786-793.
239. Guthrie, S.O.; Gordon, P.V.; Thomas, V.; Thorp, J. A.; Peabody, J.; Clark, R. H. Necrotizing Enterocolitis Among Neonates in the United States. J. Perinatol., 2003, 23, 278-285.
240. Petrenko, V.M.; Petrenko, E.V. Compensatory responses in lymph nodes following by prenatal indomethacin exposure. Morfologiia, 2001, 119(1), 37-40. Russian.
241. Morozova, E.V. Structure of the mesenteric lymph nodes in fetuses and offspring of white rats under the effect of indomethacin on the mother-fetus system. Arkh. Anat. Gistol. Embriol., 1989, 96(3), 48- 55. Russian.
242. Chakravarty, K.; Merry, P. Anticardiolipin syndrome, aspirin therapy and fetal malformation. Lupus, 1993, 2(1), 61-62. (Pubitemid 23115240)
243. Agapitos, M.; Georgiou-Theodoropoulou, M.; Koutselinis, A.; Papacharalampus, N. Cyclopia and maternal ingestion of salicylates. Pediatr. Pathol., 1986, 6(2-3),309-310. (Pubitemid 17013368)
244. Stuart, M.J.; Gross, S.J.; Elrad, H.; Graeber, J.E. Effects of acetylsalicylic- acid ingestion on maternal and neonatal hemostasis. N. Engl. J. Med., 1982, 307(15), 909-912. (Pubitemid 12011038)